Ibnsina Pharma (EGX:ISPH)

Market Cap	8.94B
Revenue (ttm)	55.84B
Net Income (ttm)	497.80M
Shares Out	1.01B
EPS (ttm)	0.49
PE Ratio	17.96
Forward PE	10.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,934,045
Average Volume	6,730,734
Open	8.73
Previous Close	n/a
Day's Range	8.65 - 8.98
52-Week Range	2.14 - 9.00
Beta	0.41
RSI	79.55
Earnings Date	May 22, 2025

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2001
• Employees: 5,500
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ISPH

Financial Performance

In 2024, Ibnsina Pharma's revenue was 55.84 billion, an increase of 64.49% compared to the previous year's 33.95 billion. Earnings were 497.80 million, an increase of 187.51%.